AllianceBernstein
TBIO

AllianceBernstein’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

AllianceBernstein’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-88,600
Closed -$2.44M – 3402
2021
Q2 		$2.44M Buy
88,600
+7,600
+9% +$149K ﹤0.01% 2069
2021
Q1 		$1.34M Buy
81,000
+1,800
+2% +$41K ﹤0.01% 2293
2020
Q4 		$1.46M Buy
79,200
+8,400
+12% +$150K ﹤0.01% 2147
2020
Q3 		$964K Sell
70,800
-9,200
-12% -$142K ﹤0.01% 2204
2020
Q2 		$1.43M Buy
80,000
+45,500
+132% +$686K ﹤0.01% 2023
2020
Q1 		$344K Buy
34,500
+3,100
+10% +$25.4K ﹤0.01% 2547
2019
Q4 		$256K Buy
31,400
+4,200
+15% +$38.8K ﹤0.01% 2832
2019
Q3 		$270K Buy
27,200
+5,500
+25% +$51.9K ﹤0.01% 2840
2019
Q2 		$274K Buy
21,700
+8,900
+70% +$93.8K ﹤0.01% 2858
2019
Q1 		$130K Buy
+12,800
New +$98.1K ﹤0.01% 2991

AllianceBernstein's TBIO Position: Q3 2021 in Review

AllianceBernstein sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 88,600 shares — an estimated $2.44M sold.

AllianceBernstein first reported a position in TBIO in Q1 2019 and held it in 10 quarters. The position peaked at $2.44M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • AllianceBernstein reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • AllianceBernstein sold 88,600 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2.44M.
  • AllianceBernstein first reported a position in Translate Bio, Inc. Common Stock in Q1 2019 and held it in 10 quarters.
  • AllianceBernstein's Translate Bio, Inc. Common Stock position peaked at $2.44M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.